JNJ vs CI
By Alex · Tickerpine
Johnson & Johnson vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CI |
|---|---|---|
| Price | $260.86 | $277.41 |
| Market cap | $628.65B | $73.30B |
| P/E ratio | 30.3 | 11.5 |
| ROE | 25.74% | 16.76% |
| Profit margin | 21.48% | 2.27% |
| Revenue growth | 6.60% | 6.70% |
| Dividend yield | 2.05% | 2.28% |
| Beta | 0.23 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CI in plain English
- JNJ is the bigger company — about 8.6× the market cap of CI.
- CI is cheaper on earnings (P/E 11.5 vs 30.3).
- JNJ earns a higher return on equity (26% vs 17%).
- CI is growing revenue faster (7% vs 7%).
- CI has the higher dividend yield (2.28% vs 2.05%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.